Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study to Evaluate the Effectiveness of BCG Vaccine in Reducing Morbidity and Mortality in Elderly Individuals in COVID-19 Hotspots in India

NCT04475302 is registered in ClinicalTrials.gov with Tuberculosis Research Centre, India as lead sponsor.

NCT NCT04475302
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04475302 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study to Evaluate the Effectiveness of BCG Vaccine in Reducing Morbidity and Mortality in Elderly Individuals in COVID-19 Hotspots in India
Lead sponsor
Tuberculosis Research Centre, India
Phase
Phase 3
Overall status
Completed
Start date
July 1, 2020
Completion date
September 20, 2021
Enrollment
2,175 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid